Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 19 Nov 2024

Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study

in Cancer Immunity and Immunotherapy

Xiaobin Chen
Qindong Cai
Lin Deng
Minyan Chen
Min Xu
Lili Chen
Yuxiang Lin
Yan Li
Yali Wang
Hanxi Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465862

1,070 views

Review

Published on 19 Nov 2024

Biological characteristics and immune responses of NK Cells in commonly used experimental mouse models

in Cancer Immunity and Immunotherapy

Jingwen Qin
Zhaokai Zhang
Haopeng Cui
Jinhua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478323

784 views

Original Research

Published on 19 Nov 2024

Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study

in Cancer Immunity and Immunotherapy

Zili Hu
Zhoutian Yang
Zibo Fu
Yizhen Fu
Zeliang Ma
Zhongguo Zhou
Minshan Chen
Yaojun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472870

1,106 views

Review

Published on 19 Nov 2024

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?

in Cancer Immunity and Immunotherapy

Jun Zou
Baisheng Xu
Peiyue Luo
Tao Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482765

1,173 views

Original Research

Published on 19 Nov 2024

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

in Cancer Immunity and Immunotherapy

Tao Wang
Shu Wang
Zhuolin Li
Jie Xie

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485123

1,167 views

Correction

Published on 18 Nov 2024

Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

in Cancer Immunity and Immunotherapy

Juhina Das
Saurav Bera
Nilanjan Ganguly
Ipsita Guha
Tithi Ghosh Halder
Avishek Bhuniya
Partha Nandi
Mohona Chakravarti
Sukanya Dhar
Anirban Sarkar

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470330

556 views

Original Research

Published on 18 Nov 2024

Long term survival and outcomes in patients with paraneoplastic neurologic syndromes

in Cancer Immunity and Immunotherapy

Sapir Bar Mucha
Ayal Rozenberg
Lilach Gutter Kapon
Alon Gorenshtein
Esther Ganelin-Cohen
Rachel Ben Hayun
Nataliya Yarovinsky
Shahar Shelly

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466704

2,003 views

Case Report

Published on 15 Nov 2024

Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

in Cancer Immunity and Immunotherapy

Tongshan Wang
Muyang Chen
Anpeng Wang
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464900

993 views
1 citation

Original Research

Published on 15 Nov 2024

Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023

in Cancer Immunity and Immunotherapy

Yiwen Bao
Zeming Mo
Shuang Wang
Jinhua Long
Honghong Zhang
Yujun Xu
Honglian Jiang
Tianbao Qian
Zhu Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475062

1,784 views
1 citation

Review

Published on 15 Nov 2024

Prospects of anti-GD2 immunotherapy for retinoblastoma

in Cancer Immunity and Immunotherapy

Xinlong Zhang
Wulin You
Yuntao Wang
Rebeka Dejenie
Chenhao Wang
Yan Huang
Jingjing Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499700

1,775 views

Original Research

Published on 15 Nov 2024

The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy

in Cancer Immunity and Immunotherapy

Amandine Decroos
Sarah Meddour
Marine Demoy
Nathalie Piccirilli
Philippe Rousselot
Franck E. Nicolini
Stéphanie Ragot
Jean-Marc Gombert
André Herbelin
Alice Barbarin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473139

1,290 views

Correction

Published on 15 Nov 2024

Corrigendum: Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing

in Cancer Immunity and Immunotherapy

Shengyi Zhang
Xinyi Zhang
Zhikai Xiahou
Shunqing Zuo
Jialong Xue
Yi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522632

599 views

Case Report

Published on 15 Nov 2024

Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up

in Cancer Immunity and Immunotherapy

Lian-Lian Li
Yue-Ping Xia
Qianqian Li
Peng Wang
Ping-Ping Sun
Xing-Guang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469251

1,619 views

Original Research

Published on 15 Nov 2024

The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease

in Cancer Immunity and Immunotherapy

Ningyuan Xi
Xiaoxiang Xu
Mingyuan Xu
Nanhui Wu
Yuhao Wu
Jiashe Chen
Shuyi Liu
Long Jiang
Guorong Yan
Guolong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435629

813 views

Review

Published on 15 Nov 2024

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications

in Cancer Immunity and Immunotherapy

Xiaohong Duan
Zhiyao Xing
Lu Qiao
Shan Qin
Xuejing Zhao
Yanhua Gong
Xueren Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495221

4,152 views
1 citation

Original Research

Published on 14 Nov 2024

Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells

in Cancer Immunity and Immunotherapy

Jiao Qu
Yueqin Zhang
Cong Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500998

953 views

Navigation group

Articles

Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study

Biological characteristics and immune responses of NK Cells in commonly used experimental mouse models

Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

Long term survival and outcomes in patients with paraneoplastic neurologic syndromes

Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023

Prospects of anti-GD2 immunotherapy for retinoblastoma

The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy

Corrigendum: Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing

Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up

The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications

Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells